|
|
Volumn 163, Issue 22, 2003, Pages 2795-2796
|
|
Cost-effective, Risk-Free, Evidence-Based Medicine [10] (multiple letters)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTILIPEMIC AGENT;
ANKLE BRACHIAL INDEX;
ARTERY DISEASE;
CLAUDICATION;
COST EFFECTIVENESS ANALYSIS;
DIAGNOSTIC TEST;
EVIDENCE BASED MEDICINE;
HIGH RISK POPULATION;
HUMAN;
LETTER;
LIPID BLOOD LEVEL;
LUNG FUNCTION TEST;
PRIMARY PREVENTION;
PRIORITY JOURNAL;
PROGNOSIS;
RISK ASSESSMENT;
RISK FACTOR;
SECONDARY PREVENTION;
VASCULAR DISEASE;
ARTERIAL OCCLUSIVE DISEASES;
BRACHIAL ARTERY;
COST-BENEFIT ANALYSIS;
HUMANS;
MEDICAL HISTORY TAKING;
PERIPHERAL VASCULAR DISEASES;
RISK FACTORS;
|
|
EID: 0345168117
PISSN: 00039926
EISSN: None
Source Type: Journal
DOI: 10.1001/archinte.163.22.2795-a Document Type: Letter |
|
Times cited : (5)
|
|
References (0)
|